Compugen Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CGEN
IL0010852080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
636.5 ILa | -0.52% | -4.57% | -7.49% |
Sales 2024 * | 37.04M 13.82B | Sales 2025 * | 41.12M 15.35B | Capitalization | 150M 55.81B |
---|---|---|---|---|---|
Net income 2024 * | -4M -1.49B | Net income 2025 * | -1M -373M | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.64 x |
P/E ratio 2024 * |
-33.4
x | P/E ratio 2025 * |
334
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | -0.52% | ||
1 week | -4.57% | ||
Current month | -0.84% | ||
1 month | -21.03% | ||
3 months | -27.43% | ||
6 months | -12.56% | ||
Current year | -7.49% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-04 | 636.5 | -0.52% | 31 397 |
24-07-03 | 639.8 | -3.03% | 107,333 |
24-07-02 | 659.8 | +0.98% | 19,591 |
24-07-01 | 653.4 | +1.79% | 14,819 |
24-06-30 | 641.9 | -0.33% | 13,599 |
Delayed Quote TEL AVIV STOCK EXCHANGE, July 04, 2024 at 10:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- CGEN Stock
- CGEN Stock